[ Price : $8.95]
FDA accepts for review a TherOx Inc. PMA for its Supersaturated Oxygen Therapy system, intended for use in reducing infarct size a...[ Price : $8.95]
FDA accepts for review an Eisai supplemental NDA for Lenvima (lenvatinib) for (XXX DELETE XXX)use in first-line treatment of patie...[ Price : $8.95]
FDA and the HHS Office for Human Research Protections issue a guidance on Minutes of Institutional Review Board (IRB) Meetings.[ Price : $8.95]
Federal Register notice: FDA publishes a list of premarket approval applications that have been approved from 7/1/2016 through 6/3...[ Price : $8.95]
FDA updates a 2016 safety alert to transplant surgeons and cardiologists about additional data that continue to indicate that ther...[ Price : $8.95]
FDA and several ophthalmic-related medical associations announce a 10/23 workshop entitled Ophthalmic Digital Health to discuss fa...[ Price : $8.95]
FDA makes available a guidance on Expedited Programs for Serious Conditions Drugs and Biologics.[ Price : $8.95]
FDA deploys additional staff to Puerto Rico to work with pharmaceutical and device companies to prevent shortages of medically nec...